Ignite Creation Date:
2024-05-06 @ 7:40 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02579616
Status:
COMPLETED
Last Update Posted:
2020-12-23
First Post:
2015-10-16
Brief Title:
Study of Lenvatinib E7080 in Unresectable Biliary Tract Cancer BTC Who Failed Gemcitabine-based Combination Chemotherapy
Sponsor:
Eisai Co Ltd
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
E7080-J081-215
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None